β€” 01 / Company

One commercial wedge for seven frontier programs.

Planckchron is building HERA Nexus as the near-term entry point for an evidence-led architecture spanning clinical decision support, emerging compute, biotechnology, autonomous systems, resilient communications, and aerospace research.

One company thesisAccountable intelligence and evidence for frontier systems
One commercial wedgeHERA Nexus concentrates near-term execution
Seven product programsEvery product remains behind a defined evidence gate
No inflated readinessTargets remain separate from validated results

Competitive posture

Partner with domain leaders. Build the accountable operating layer.

Planckchron is not publicly representing itself as a scaled foundation-model company, fabricated quantum-hardware manufacturer, clinical-stage drug company, operational communications network, or flight-ready aerospace company. Its thesis is that reusable intelligence, evidence, governance, and human-control patterns can compound across those domains.

See the architecture

Corporate record

Small enough to focus. Structured to compound.

The company is early-stage and pre-revenue unless documentary evidence supports a later update. Public product pages describe research direction, design work, and prototype objectivesβ€”not independently validated commercial performance unless expressly stated.

Founded

2018

Incorporated

2025-08-13

Entity

Delaware C-Corporation

Headquarters

Los Angeles, California

Stage

Founder-led, early-stage and pre-revenue

Build with us

Bring one consequential workflow and a willingness to measure failure.

Planckchron is seeking design partners, technical reviewers, strategic investors, and government collaborators with a real operating boundary, accountable owner, defined evidence plan, and practical milestone.